| 注册
首页|期刊导航|肿瘤预防与治疗|NSCLC根治术后 pN2 期患者不同放化疗模式的疗效分析

NSCLC根治术后 pN2 期患者不同放化疗模式的疗效分析

Li Xiujuan Luo Xingbo Zhang Jing Xie Xiaohui Peng Xiaoqin Yao Wenxiu

肿瘤预防与治疗2019,Vol.32Issue(4):311-318,8.
肿瘤预防与治疗2019,Vol.32Issue(4):311-318,8.DOI:10. 3969/j. issn. 1674-0904. 2019. 04. 004

NSCLC根治术后 pN2 期患者不同放化疗模式的疗效分析

Effect of Different Radiotherapy and Chemotherapy Modes on Patients with pN2 Stage NSCLC after Radical Operation

Li Xiujuan 1Luo Xingbo 1Zhang Jing 1Xie Xiaohui 1Peng Xiaoqin 1Yao Wenxiu2

作者信息

  • 1. Chengdu medical College, Chengdu 610500, Sichuan, China
  • 2. Department of Thoracic Oncology, Sichuan Cancer Hospital&Institute, Sichuan Cancer Center, School of medicine, University of Electronic Science and Technology of China, Chengdu 610041, Sichuan, China
  • 折叠

摘要

Abstract

Objective: To compare the value of sequential radiochemotherapy (SCRT) and concurrent chemoradiotherapy (CCRT) in adjuvant treatment of pN2 patients with non-small cell lung cancer (NSCLC) after radical resection. Methods:Ninety-two pN2 NSCLC patients after surgery in Sichuan cancer hospital from January 2012 to December 2017 were selected and divided into two groups, SCRT group (n=54) and CCRT group (n=38), according to different chemoradiotherapies. Side effects, local recurrence free survival (LRFS), distant metastasis free survival (DmFS), disease-free survival (DFS), overall survival ( OS) and 1- , 2-and 3-year survival rates were compared between the two groups. Results: There was no significant difference in general information, pathological type, pathological T stage and lymph node status between the two groups. The incidence of leukopenia in CCRT group was higher than that in SCRT group (P<0. 05). There was no significant difference between the two groups in the incidence of side effects such as radiation esophagitis and radiation pneumonia (P>0. 05). Median DmFS and DFS in SCRT group were better than those in CCRT group. Median LRFS in both groups and median OS in the CCRT group were not retrieved. But the differences were not significantly different between the two groups in median DmFS, DFS, LRFS and OS (P>0. 05). Conclusion: For pN2 stage NSCLC patients underwent radical resection, SCRT and CCRT are effective treatment methods, and the safety of SCRT is better. DmFS and DFS from SCRT are better than those from CCRT. The value of SCRT and CCRT needs to be further explored.

关键词

N2/非小细胞肺癌/序贯/同步/放化疗

Key words

N2/Non small cell lung cancer/Sequential/Concurrent/Chemoradiotherapy

分类

医药卫生

引用本文复制引用

Li Xiujuan,Luo Xingbo,Zhang Jing,Xie Xiaohui,Peng Xiaoqin,Yao Wenxiu..NSCLC根治术后 pN2 期患者不同放化疗模式的疗效分析[J].肿瘤预防与治疗,2019,32(4):311-318,8.

基金项目

吴阶平医学基金会临床科研专项资助基金课题(编号: 320. 6750. 12670) This study was supported by Clinical Research Project of Wu Jieping medical Foundation (NO. 320. 6750. 12670) . (编号: 320. 6750. 12670)

肿瘤预防与治疗

OACSTPCD

1674-0904

访问量0
|
下载量0
段落导航相关论文